- Home
- TRAW vs CNFR Comparison
TRAW vs CNFR Comparison
Compare TRAW & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAW
- CNFR
- Stock Information
- Founded
- TRAW 1998
- CNFR 2009
- Country
- TRAW United States
- CNFR United States
- Employees
- TRAW N/A
- CNFR N/A
- Industry
- TRAW
- CNFR Property-Casualty Insurers
- Sector
- TRAW
- CNFR Finance
- Exchange
- TRAW NYSE
- CNFR Nasdaq
- Market Cap
- TRAW 8.6M
- CNFR 9.4M
- IPO Year
- TRAW 2013
- CNFR 2015
- Fundamental
- Price
- TRAW $1.58
- CNFR $0.90
- Analyst Decision
- TRAW
- CNFR
- Analyst Count
- TRAW 0
- CNFR 0
- Target Price
- TRAW N/A
- CNFR N/A
- AVG Volume (30 Days)
- TRAW 71.7K
- CNFR 6.6K
- Earning Date
- TRAW 08-14-2025
- CNFR 08-12-2025
- Dividend Yield
- TRAW N/A
- CNFR N/A
- EPS Growth
- TRAW N/A
- CNFR N/A
- EPS
- TRAW N/A
- CNFR 1.96
- Revenue
- TRAW $227,000.00
- CNFR $64,021,000.00
- Revenue This Year
- TRAW $3.81
- CNFR $25.91
- Revenue Next Year
- TRAW $30.43
- CNFR N/A
- P/E Ratio
- TRAW N/A
- CNFR $0.45
- Revenue Growth
- TRAW 0.44
- CNFR N/A
- 52 Week Low
- TRAW $0.97
- CNFR $0.42
- 52 Week High
- TRAW $19.44
- CNFR $1.91
- Technical
- Relative Strength Index (RSI)
- TRAW 50.55
- CNFR 64.66
- Support Level
- TRAW $1.47
- CNFR $0.81
- Resistance Level
- TRAW $1.73
- CNFR $0.96
- Average True Range (ATR)
- TRAW 0.10
- CNFR 0.06
- MACD
- TRAW 0.01
- CNFR 0.01
- Stochastic Oscillator
- TRAW 50.00
- CNFR 70.26
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.